Abstract
Most of the data on the use of Letrozole in poor responder patients combine Letrozole with high-dose gonadotropins (Gn) (225-600IU). Our aim is to compare pregnancy outcomes of mild ovarian stimulation with 150 IU rFSH/HMG in combination with (Let-Gn-ant) or without Letrozole (Gn-ant) in patients with diminished ovarian reserve (DOR) undergoing IVF-ICSI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
